Research proposal on the relationship between plasma taurine concentration and cerebral edema in neurosurgical patients
DOI:
https://doi.org/10.31157/an.v1iInpress.423Keywords:
taurine, brain edema, brain tumor, sucarachnoid hemorrhageReferences
Barges-Coll J, Pérez-Neri I, Avendaño J, Mendez-Rosito D, Gomez-Amador JL, Ríos C. Plasma taurine as a predictor of poor outcome in patients with mild neurological deficits after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2013;119(4):1021-1027. DOI: https://doi.org/10.3171/2013.4.JNS121558
Pérez-Neri I, Barges-Coll J, Ramírez-Bermúdez J, García-López R, Ojeda-López C, Méndez-Rosito D et al. Taurina es un marcador de pronóstico, complicaciones y supervivencia de pacientes con diferentes trastornos neurológicos. Arch Neurocien. 2011;16(Supl II):22-24.
Manrique-Carmona LP, Pérez-Neri I. Pathophysiology and Treatment of Peritumoral Brain Edema: Possible Effect of Lidocaine. Neurochemical Journal. 2018;12(1):9-14. DOI: https://doi.org/10.1134/S1819712418010099
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.